oxidopamine has been researched along with 4-methyl-7-ethoxycoumarin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Fan, S; Feng, Y; Huang, C; Huang, X; Jiang, X; Li, F; Li, H; Wu, X; Yuan, J; Zhang, Y; Zhou, Z | 1 |
1 other study(ies) available for oxidopamine and 4-methyl-7-ethoxycoumarin
| Article | Year |
|---|---|
Pepper component 7-ethoxy-4-methylcoumarin, a novel dopamine D2 receptor agonist, ameliorates experimental Parkinson's disease in mice and Caenorhabditis elegans.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Cell Line; Coumarins; Disease Models, Animal; Dopamine Agonists; Humans; Locomotion; Male; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Receptors, Dopamine D2 | 2021 |